Banks Calls on Federal Trade Commission to Probe Abortion Drug Companies Over Alleged Deceptive Safety ClaimsMonday, April 20, 2026
sent a letter to the Federal Trade Commission Chairman, Andrew Ferguson, urging the Commission to investigate abortion drug … gender medicine, you affirmed that the Federal Trade Commission has jurisdiction over false and misleading medical claims.1